Literature DB >> 11490302

The influence of sex hormones on renal osteopontin expression and urinary constituents in experimental urolithiasis.

T Yagisawa1, F Ito, Y Osaka, H Amano, C Kobayashi, H Toma.   

Abstract

PURPOSE: To our knowledge the influence of sex hormones on urinary stone formation remains undetermined. We investigated the effect of castration on urinary lithogenic factors and renal osteopontin expression in rats previously treated with ethylene glycol.
MATERIALS AND METHODS: Sprague-Dawley rats were divided normal males, castrated males, males with 2 weeks of 0.75% ethylene glycol treatment, castrated males with 2 weeks of 0.75% ethylene glycol treatment, normal females, castrated females, females with 2 weeks of 0.75% ethylene glycol treatment and castrated females with 2 weeks of 0.75% ethylene glycol treatment. We analyzed 24-hour urine samples for urinary constituents, such as calcium, oxalate, citrate, uric acid, phosphate, magnesium, sodium, potassium and creatinine. The kidneys were examined for osteopontin expression by Northern blot analysis and for crystal deposition by histological examination.
RESULTS: In intact male rats calcium and citrate excretion decreased and oxalate excretion increased significantly after ethylene glycol treatment. Castrated male rats with ethylene glycol had greater calcium and less oxalate excretion than male intact rats with ethylene glycol. In intact female rats uric acid excretion decreased and only calcium excretion increased significantly after ethylene glycol treatment. Castrated female rats with ethylene glycol excreted significantly more oxalate and less calcium than intact female rats with ethylene glycol. Renal osteopontin expression was the same in male intact and castrated rats, and in female intact and castrated rats. In males with ethylene glycol expression was stronger in castrated than in intact rats. In females with ethylene glycol expression was weaker in castrated than in intact rats. No crystal deposits were found in the kidneys in any group.
CONCLUSIONS: Testosterone appears to promote stone formation by suppressing osteopontin expression in the kidneys and increasing urinary oxalate excretion. Estrogen appears to inhibit stone formation by increasing osteopontin expression in the kidneys and decreasing urinary oxalate excretion.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11490302

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  29 in total

Review 1.  Kidney stones.

Authors:  Malvinder S Parmar
Journal:  BMJ       Date:  2004-06-12

2.  Antioxidants inhibition of high plasma androgenic markers in the pathogenesis of ethylene glycol (EG)-induced nephrolithiasis in Wistar rats.

Authors:  Mohammad Reza Naghii; Mahmood Mofid; Mehdi Hedayati; Kazem Khalagi
Journal:  Urolithiasis       Date:  2013-11-08       Impact factor: 3.436

3.  Incorporation of osteopontin peptide into kidney stone-related calcium oxalate monohydrate crystals: a quantitative study.

Authors:  Jared S Gleberzon; Yinyin Liao; Silvia Mittler; Harvey A Goldberg; Bernd Grohe
Journal:  Urolithiasis       Date:  2018-12-19       Impact factor: 3.436

Review 4.  Prevalence, pathophysiological mechanisms and factors affecting urolithiasis.

Authors:  Aslam Khan
Journal:  Int Urol Nephrol       Date:  2018-03-22       Impact factor: 2.370

5.  Relation of urinary stone disease with androgenetic alopecia and serum testosterone levels.

Authors:  Emre Can Polat; Levent Ozcan; Alper Otunctemur; Emin Ozbek
Journal:  Urolithiasis       Date:  2016-05-07       Impact factor: 3.436

6.  Testosterone replacement therapy is associated with an increased risk of urolithiasis.

Authors:  Tyler R McClintock; Marie-Therese I Valovska; Nicollette K Kwon; Alexander P Cole; Wei Jiang; Martin N Kathrins; Naeem Bhojani; George E Haleblian; Tracey Koehlmoos; Adil H Haider; Shehzad Basaria; Quoc-Dien Trinh
Journal:  World J Urol       Date:  2019-03-23       Impact factor: 4.226

7.  An assessment of parathyroid hormone, calcitonin, 1,25 (OH)2 vitamin D3, estradiol and testosterone in men with active calcium stone disease and evaluation of its biochemical risk factors.

Authors:  Nasser Shakhssalim; Kobra Roohi Gilani; Mahmoud Parvin; Peyman Mohammadi Torbati; Amir H Kashi; Mohaddeseh Azadvari; Banafsheh Golestan; Abbas Basiri
Journal:  Urol Res       Date:  2010-05-19

8.  Influence of estrus status on urinary chemical parameters related to urolithiasis.

Authors:  Yuji Kato; Satoshi Yamaguchi; Hidehiro Kakizaki; Sunao Yachiku
Journal:  Urol Res       Date:  2005-11-26

9.  Is polycystic ovarian syndrome a risk factor for urolithiasis?

Authors:  Ikbal Kaygusuz; Omer Faruk Karatas; Hasan Kafali; Ersin Cimentepe; Dogan Unal
Journal:  Urolithiasis       Date:  2013-04-21       Impact factor: 3.436

10.  Family history in stone disease: how important is it for the onset of the disease and the incidence of recurrence?

Authors:  Hakan Hasbey Koyuncu; Faruk Yencilek; Bilal Eryildirim; Kemal Sarica
Journal:  Urol Res       Date:  2010-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.